Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Infectious Diseases Epidemiology

Our team’s vision is to reduce the burden of infectious diseases in children and their families through comprehensive approaches to understanding the burden of disease, developing and optimising diagnosis and treatment strategies and evaluating and informing current and future prevention programs.

Our group has a particular interest in acute lower respiratory infections, commonly known as chest infections.

These conditions include bronchiolitis and pneumonia and occurs secondary to viral and bacterial infections including viral pathogens respiratory syncytial virus (RSV), influenza, human metapneumovirus and parainfluenza virus and bacterial pathogens including Streptococcus pneumoniae and Bordetella pertussis. Chest infections are a major cause of childhood morbidity with some population subgroups experiencing higher rates of severe disease including Aboriginal and/or Torres Strait Islander children, those with co-morbidities and those from a lower socio-economic background.

The work of the Infectious Disease Epidemiology team centres around three key themes:

  • Burden of Disease – understanding pathogen-specific burden of disease, temporal and seasonal trends in disease and perinatal risk factors to disease in population groups using a range of data sources.
  • Prevention and Policy – evaluating current prevention policy, such as vaccination policy at local and population levels, incorporating assessment of vaccine coverage, cost effectiveness and overall program performance in reducing the incidence of disease. We also use data to advocate for new immunisation programs, including RSV.
  • Diagnosis and Treatment - developing ways to improve surveillance of and the diagnosis and treatment of severe respiratory infections in children through prospective cohort studies, clinical trials and use of administrative health data.

Our team employs an array of methodologies including epidemiological analyses of large-scale population-based linked administrative health data; statistical and mathematical modelling; undertaking prospective cohort studies and clinical trials; and conducting social research.

Team leader

Associate Professor Hannah Moore
Associate Professor Hannah Moore

OAM BSc (Hons) GradDipClinEpi PhD

Program Head, Infection and Vaccines

Professor  Christopher Blyth
Professor Christopher Blyth

MBBS (Hons) DCH FRACP FRCPA PhD

Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and Infectious Diseases, Honorary and NHMRC Emerging Leadership Fellow

Team members (18)

Anita Williams
Anita Williams

MInfecDis MPhil(App Epi)

Research Officer, Infectious Diseases Epidemiology

Belaynew Taye
Belaynew Taye

MD, MPH, PhD

Research Officer, Infectious Disease Epidemiology

Carla Puca
Carla Puca

BSc, MPH, MIDI

Honorary Team Member, Research Nurse

Dr Minda Sarna
Dr Minda Sarna

M.App.Epid., PhD

Senior Research Officer

Huong Le
Huong Le

MA (Dev. Econ), MA (App. Stats), PhD (Econ)

Biostatistician & Data Analyst

Carolyn Finucane

Carolyn Finucane

Research Nurse

Cathy Pienaar

Cathy Pienaar

Honorary Team Member

Charlie Holland

Charlie Holland

PhD Student

Daniel Oakes

Daniel Oakes

Research Assistant

David Foley

David Foley

PhD Student

Fiona Giannini

Fiona Giannini

Mathematical Modeller

Dhruv Shah

Dhruv Shah

Program Manager, Infectious Diseases Epidemiology Team

Joanne Harvey

Joanne Harvey

Clinical Trial Coordinator

Kate Britton

Kate Britton

PhD Student

Kate Turnock

Kate Turnock

Executive Support Officer

Sultan Mahmood

Sultan Mahmood

PhD Student

Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort study

Invasive fungal disease (IFD) is a common and important complication in children with acute myeloid leukaemia (AML). We describe the epidemiology of IFD in a large multicentre cohort of children with AML.

Antimicrobial Resistance in Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa Isolates From Bloodstream Infections in Australian Children, 2013–2021

Gram-negative bloodstream infections are associated with significant morbidity and mortality in children. Increasing antimicrobial resistance (AMR) is reported globally, yet efforts to track pediatric AMR at a national level over time are lacking.  

Australian Group on Antimicrobial Research surveillance outcome programs - bloodstream infections and antimicrobial resistance patterns from patients less than 18 years of age

From 1 January 2020 to 31 December 2021, thirty-eight institutions across Australia submitted data to the Australian Group on Antimicrobial Resistance (AGAR) from patients aged < 18 years (AGAR-Kids). Over the two years, 1,679 isolates were reported from 1,611 patients. This AGAR-Kids report aims to describe the population of children and adolescents with bacteraemia reported to AGAR and the proportion of resistant isolates.  

Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care

Acute lower respiratory infections (ALRIs) are a major contributor to the global infectious disease burden and a common cause of hospitalisation for children under 2 years. We compared clinical severity in children hospitalised with respiratory syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV) and influenza virus (IFV).

Show all
Infectious Diseases Epidemiology

Videos